Dermatology News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–8 of 8 articles
Takeda TYK2 drug tops Bristol Myers’ Sotyktu in psoriasis head-to-head test
Nektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes
Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas
Sagimet Biosciences Plans Phase 3 Denifanstat Trial for Acne Treatment in 2026
Veradermics VDPHL01 Phase 2/3 Trial Results for Male Pattern Hair Loss to Be Announced
Veradermics VDPHL01 Phase 2/3 Trial Results: Conference Call Scheduled for Oral Minoxidil Hair Loss Treatment
Psoriasis Treatment Pipeline Explodes: 90+ Companies Race to Develop Next-Generation Therapies in 2026
FDA Approves Litfulo: Key Facts on Pfizer’s Alopecia Treatment